Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Haploidentical hematopoietic cell transplantation

Bone Marrow Transplantation volume 42, pages S60–S63 (2008)Cite this article

Abstract

Haploidentical hematopoietic stem cell transplantation (HSCT) provides an opportunity for nearly all patients to benefit from HCT when a HLA genotypically matched sibling is not available. Initial results with the use of mismatched allografts led to limited enthusiasm due to GVHD and infectious complications resulting in unacceptable treatment-related morbidity and mortality. Recent advances with effective T-cell depletion, the use of ‘megadoses’ of stem cells, better antimicrobial therapy and reduced intensity conditioning has significantly decreased the early transplant-related mortality and GVHD. These modifications also enabled robust and prompt engraftment and led to enhancing the therapeutic benefits of haploidentical transplantation. However, the cardinal problems related to delayed immune reconstitution causing post-transplant infectious complications and relapse remain, limiting the efficacy of haploidentical transplant. Preliminary data have demonstrated the great potential in the use of adoptive cellular immunity and selective allodepletion in rapidly reconstituting immunity without GVHD. The encouraging reports from haploidentical transplant using noninherited maternal antigen (NIMA)-mismatched donors or natural killer (NK) alloreactive donors may greatly increase the donor availability and open a way to more appropriate donor selection in HLA-haploidentical HSCT. Future challenges remain in determining the safest approach for haploidentical transplant with minimal risk of GVHD, while preserving effective GVL activity and promoting prompt immune reconstitution.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Confer DL . Unrelated marrow donor registries. Curr Opin Hematol 1997; 4: 408–412.

    Article  CAS  PubMed  Google Scholar 

  2. Beatty PG, Mori M, Milford E . Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation 1995; 60: 778–783.

    Article  CAS  PubMed  Google Scholar 

  3. Hansen JA, Petersdorf E, Martin PJ, Anasetti C . Hematopoietic stem cell transplants from unrelated donors. Immunol Rev 1997; 157: 141–151.

    Article  CAS  PubMed  Google Scholar 

  4. Howe CWS, Radde-Stepaniak T . Hematopoietic cell donor registries. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 2nd edn. Blackwell Science: Malden, MA, 1999, pp 503–512.

    Google Scholar 

  5. Davies SM, Kollman C, Anasetti C, Antin JH, Gajewski J, Casper JT et al. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood 2000; 96: 4096–4102.

    CAS  PubMed  Google Scholar 

  6. McGlave PB, Shu XO, Wen W, Anasetti C, Nademanee A, Champlin R et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. Blood 2000; 95: 2219–2225.

    CAS  PubMed  Google Scholar 

  7. Anasetti C . Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia. Leukemia 2000; 14: 502–504.

    Article  CAS  PubMed  Google Scholar 

  8. Sierra J, Storer B, Hansen JA, Martin PJ, Petersdorf EW, Woolfrey A et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant 2000; 26: 397–404.

    Article  CAS  PubMed  Google Scholar 

  9. Aversa F, Velardi A, Tabilio A, Reisner Y, Martelli MF . Haploidentical stem cell transplantation in leukemia. Blood Rev 2001; 15: 111–119.

    Article  CAS  PubMed  Google Scholar 

  10. Rocha V, Wagner Jr JE, Sobocinkski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 2000; 342: 1846–1854.

    Article  CAS  PubMed  Google Scholar 

  11. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.

    Article  CAS  PubMed  Google Scholar 

  12. Long GD, Laughlin M, Madan B, Kurtzberg J, Gasparetto C, Morris A et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003; 9: 772–780.

    Article  PubMed  Google Scholar 

  13. Lang P, Bader P, Schumm M, Feuchtinger T, Einsele H, Führer M et al. Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. Br J Haematol 2004; 124: 72–79.

    Article  PubMed  Google Scholar 

  14. Kawano Y, Takaue Y, Watanabe A, Takeda O, Arai K, Itoh E et al. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor. Blood 1998; 92: 3123–3130.

    CAS  PubMed  Google Scholar 

  15. Peters C, Matthes-Martin S, Fritsch G, Holter W, Lion T, Witt V et al. Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia 1999; 13: 2070–2078.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Passweg JR, Kuhne T, M Gregor M, Favre G, Avoledo P, Tichelli A et al. Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants. Bone Marrow Transplantation 2000; 26: 1033–1036.

    Article  CAS  PubMed  Google Scholar 

  17. Henslee-Downey PJ . Allogeneic transplantation across major HLA barriers. Best Pract Res Clin Haematol 2001; 14: 741–754.

    Article  CAS  PubMed  Google Scholar 

  18. Rizzieri DA, Koh LP, Long GD, Gasparetto C, Sullivan KM, Horwitz M et al. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol 2007; 25: 690–697.

    Article  CAS  PubMed  Google Scholar 

  19. Barfield RC, Otto M, Houston J, Holladay M, Geiger T, Martin J et al. A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation. Cytotherapy 2004; 6: 1–6.

    Article  CAS  PubMed  Google Scholar 

  20. Hale G, Kimberly K, Lovins R, Woodard J, Leung W, Yusuf U et al. CD3 Depleted hematopoietic peripheral blood stem cell grafts in children with refractory hematologic malignancies undergoing transplantation from mismatched related donors [abstract]. Blood 2005; 106: 451b.

    Google Scholar 

  21. Bethge WA, Haegele M, Faul C, Lang P, Schumm M, Bornhauser M et al. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. Exp Hematol 2006; 34: 1746–1752.

    Article  CAS  PubMed  Google Scholar 

  22. Handgretinger R, Chen X, Pfeiffer M, Mueller I, Feuchtinger T, Hale GA et al. Feasability and outcome of reduced intensity conditioning in haploidentical transplantation. Ann N Y Acad Sci 2007; 1106: 279–289.

    Article  CAS  PubMed  Google Scholar 

  23. Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG et al. Lymphohematopoietic graft-vs-host reactions can be induced without graft-vs-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Biol Blood Marrow Transplant 1999; 5: 133–143.

    Article  CAS  PubMed  Google Scholar 

  24. Spitzer TR, McAfee SL, Dey BR, Colby C, Hope J, Grossberg H et al. Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies. Transplantation 2003; 75: 1448–1751.

    Article  Google Scholar 

  25. Dey BR, Spitzer TR . Current status of haploidentical stem cell transplantation. Br J Haematol 2006; 135: 423–437.

    Article  PubMed  Google Scholar 

  26. Spitzer TR . Haploidentical stem cell transplantation: the always present but overlooked donor. Hematology Am Soc Hematol Educ Program 2005, 390–395.

    Article  Google Scholar 

  27. O'Donnell PV, Luznik L, Jones RJ, Vogelsang GB, Leffell MS, Phelps M et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2002; 8: 377–386.

    Article  CAS  PubMed  Google Scholar 

  28. Ogawa H, Ikegame K, Yoshihara S . Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 2006; 12: 1073–1084.

    Article  PubMed  Google Scholar 

  29. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756–763.

    CAS  PubMed  Google Scholar 

  30. Kanda Y, Oshima K, Asano-Mori Y, Kandabashi K, Nakagawa M, Sakata-Yanagimoto M et al. In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation. Transplantation 2005; 79: 1351–1357.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Duke University, Durham, NC, USA

    L-P Koh & N Chao

Authors
  1. L-P Koh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Chao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N Chao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koh, LP., Chao, N. Haploidentical hematopoietic cell transplantation. Bone Marrow Transplant 42 (Suppl 1), S60–S63 (2008). https://doi.org/10.1038/bmt.2008.117

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.117

Keywords

This article is cited by

Search

Advanced search

Quick links